RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Currently Enrolling
Observational

The TANGO Study

The TANGO Study for Post-Transplant Glomerular Diseases

Brief Description

The TANGO study aims to create a large international network of centers to study glomerular disease (GN) recurrence after renal transplantation.

Trial Physician / Study Coordinator

Enver Akalin

Email Phone
Site Name

Montefiore Medical Center, Albert Einstein College of Medicine
1825 Eastchester Rd, The Bronx, NY 10461, USA

If there is not a site for a clinical trial nearby, you can ask the study team about the possibility of travel reimbursements (i.e., paying you back for your travel costs). Alternatively, you can ask about the possibility of participating from home.
Currently Enrolling
Observational

The TANGO Study

The TANGO Study for Post-Transplant Glomerular Diseases

Brief Description

The TANGO study aims to create a large international network of centers to study glomerular disease (GN) recurrence after renal transplantation.

Trial is for people with

The TANGO study will enroll adult (≥18 years) patients with a biopsy-proven primary Glomerular Disease (IgA nephropathy, Membranous glomerulonephritis, Focal and segmental glomerulosclerosis, Atypical hemolytic uremic syndrome, Membranoproliferative glomerulonephritis old classification type I-III, Complement- or IgG-positive membranoproliferative, glomerulonephritis, Dense-deposit disease, C3 glomerulonephritis) as the designated cause of their end-stage kidney disease who underwent a kidney transplant starting in January 2005 or later.

Study Goal

The purpose of the TANGO study is to create a large international network of centers to study kidney disease that recur after renal transplantation. Since many of these kidney diseases that recur are rare, it is crucial that we involve many centers around the world to collect individualized information that will help to understand the disease and identify new treatments.

What is involved for the Patient?

Your clinical information and samples (blood and urine) will be analyzed anonymously. This will help better understand individual diseases and potentially identify new potential treatments. You may choose to be contacted in the future as discoveries are made and potential novel treatments become available for your condition.

About the drug or intervention

Learn more at http://tangoxstudy.com

New York, NY (Montefiore Medical Center)
Frequently Asked Questions

Nephrotic Syndrome is not a disease itself, but rather a group of signs and symptoms that result from damage in the part of the kidney that filters blood (glomeruli).

Common symptoms include:

  • Foamy urine (called proteinuria) caused by protein “spilling” into the urine
  • Severe swelling in parts of the body, most noticeably around the eyes, hands, feet, and abdomen (called edema)
  • Weight gain due to a buildup of extra fluid
  • Fatigue
  • Loss of appetite
  • Low levels of protein in the blood (hypoalbuminemia)
  • Higher than normal fat and cholesterol levels in the blood (hyperlipidemia)

Nephrotic Syndrome can typically be diagnosed with a urine test.

Nephrotic Syndrome can be “primary” or “secondary” in nature.

Diseases that affect only the kidneys are called primary causes of Nephrotic Syndrome. Doctors often call these diseases “idiopathic,” which means that they arise from an unknown cause. Some of these diseases include:

  • Minimal Change Disease (MCD) – most common in children
  • Focal Segmental Glomerulosclerosis (FSGS)
  • Membranous Nephropathy (MN) – most common in adults
  • IgA Nephropathy (IgAN)

Secondary Nephrotic Syndrome is caused by an underlying, systemic condition like diabetes, lupus, HIV, and others.

Clinical studies are any studies that involve people. There are two main types: observational and interventional. In an observational trial, researchers track health outcomes over time in groups of participants to look for patterns that help us better understand a disease. In an interventional trial, participants receive specific interventions, which can include new treatments or behavorial changes (e.g., diet changes). To learn more about clinical research, please visit the NephCure website.